Offerings / Regulation CF / Fisher Wallace Laboratories, Inc.
Fisher Wallace Laboratories, Inc.
Regulation Crowdfunding offering on DealMaker Securities · Form C filed January 30, 2026 · Brooklyn, New York
Repeat issuerCommon stockEarly revenueCorporation, Delaware
Business summary pending extraction from the offering statement. The company is a corporation organized in Delaware on August 23, 2019, based in Brooklyn, NY, with 5 employees and $47,412 of revenue in its most recent fiscal year.
Offering terms
- Security
- Common Stock
- Maximum
- $2,587,498.09
- Price
- $11.21 per unit
- Pricing method
- Not stated
- Deadline
- February 20, 2026
- Oversubscriptions
- Accepted
- Intermediary
- DEALMAKER SECURITIES LLC
Broker-dealer, SEC file 008-70756 - Intermediary fee
- Up to 8.5%
- Intermediary equity
- None
Financials as filed
| Item | Most recent FY | Prior FY |
|---|---|---|
| Revenue | $47,412 | $2,019,527 |
| Cost of goods sold | $3,012 | $350,736 |
| Net income (loss) | -$1,579,900 | -$1,644,382 |
| Total assets | $154,382 | $361,017 |
| Cash and equivalents | $41,626 | $311,160 |
| Accounts receivable | $0 | $0 |
| Short-term debt | $596,720 | $569,243 |
| Long-term debt | $940,656 | $866,830 |
| Taxes paid | $0 | $0 |
Two fiscal years as reported on the Form C cover sheet. 5 employees. Offered in 64 states.